A new study has reported that the early use of zinc together with a low dose hydroxychloroquine and azithromycin is associated with five times fewer hospitalizations in COVID-19 patients.
The study, which is awaiting peer-review (pdf), was conducted by Dr. Vladimir Zelenko, a New York-based primary care physician, in collaboration with Dr. Roland Derwand, a German medical doctor and life science industry expert, and Professor Martin Scholz, an independent consultant and adjunct professor for experimental medicine at Heinrich Heine University, Düsseldorf, Germany.
